跳至主要内容
临床试验/NCT03913936
NCT03913936已完成不适用

Young, Empowered & Strong (YES): The Young Women's Breast Cancer Study 2- Focus on Intervention Pilot

Dana-Farber Cancer Institute1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2019年5月23日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
30
试验地点
1
主要终点
Participant-reported utility of the portal.

研究概览

简要总结

This research study is piloting a new internet-based research tool (YES portal). The main purpose of this pilot study is to test the web-based interface.

详细描述

This study is being done to pilot a web-based research intervention tool. The investigators hope that by piloting it with the participants they can improve the tool and the other processes. The main purpose of this pilot study is to test the web-based interface, the participant's engagement with the platform, and the recruitment procedures. This initial pilot study will inform the design of a larger study intended to monitor common symptoms and behavior, and to provide supportive care information and research opportunities in an iterative manner for young women who have been diagnosed with breast cancer using the YES portal, built for smartphones, tablets, and computers.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 44 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Between the ages of 18-44 years
  • A history of breast cancer; we will pilot in 3 separate cohorts consisting of 10 patients each: newly diagnosed patients receiving care at DFCI, prevalent survivors who have completed early active therapy (surgery, chemotherapy and/or radiotherapy) and are being followed at DFCI, and women living with advanced breast cancer receiving care at DFCI
  • Be fluent in and able to read English
  • Have internet access on a regular basis at the time of consent that can support the web-based platform

排除标准

  • 未提供

研究组 & 干预措施

LIVING WITH ADVANCED DISEASE

Experimental
  • Participants will track their symptoms with weekly and monthly standard surveys to monitor for symptoms.
  • The YES portal is designed to collect and assess participants' toxicities and symptoms, as well as informational needs in between visits with their clinician

干预措施: YES portal (Other)

NEWLY DIAGNOSED

Experimental

Participants will track their symptoms with weekly and monthly standard surveys to monitor for symptoms.

The YES portal is designed to collect and assess participants' toxicities and symptoms, as well as informational needs in between visits with their clinician

干预措施: YES portal (Other)

SURVIVOR

Experimental
  • Participants will track their symptoms with weekly and monthly standard surveys to monitor for symptoms.
  • The YES portal is designed to collect and assess participants' toxicities and symptoms, as well as informational needs in between visits with their clinician

干预措施: YES portal (Other)

结局指标

主要结局

Participant-reported utility of the portal.

时间窗: 2 years

Investigator developed questions will be used to assess the utility of the portal including the perceived usefulness of portal in addressing symptoms and needs and ease of use.

Frequency of information downloads.

时间窗: 2 years

To measure the number of times participants download the resource sources provided through data collected from back-end of portal.

Frequency of logging into the portal.

时间窗: 2 years

To measure the number of times participants engage with the portal using log in data collected from back-end of portal.

Participant-reported recommendations for improving the portal.

时间窗: 2 years

Investigator developed questions asking participants for feedback pertaining to ways to improve the portal and processes.

Time spent in the portal.

时间窗: 2 years

To summarize the number of hours/minutes the participant spent using portal through data collected from back-end of portal.

Time spent responding the survey.

时间窗: 2 years

To summarize the number of hours/minutes the survey takes to complete through data collected from back-end of portal.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ann H. Partridge, MD, MPH

Principal Investigator

Dana-Farber Cancer Institute

研究点 (1)

Loading locations...

相似试验